Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 AUD | -13.04% | -16.67% | +81.82% |
May. 01 | Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6% | MT |
Apr. 09 | Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Brookes
CEO | Chief Executive Officer | 63 | 19-01-22 |
John Michailidis
COO | Chief Operating Officer | - | - |
Simon Erskine
PRN | Corporate Officer/Principal | - | 21-12-05 |
Stephen Denaro
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Brookes
CEO | Chief Executive Officer | 63 | 19-01-22 |
John Michailidis
COO | Chief Operating Officer | - | - |
Nicholas Haslam
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,893,727 | 107,260,729 ( 63.89 %) | 0 | 63.89 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+81.82% | 5.11M | |
+33.17% | 700B | |
-4.94% | 358B | |
+19.04% | 330B | |
+3.65% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.50% | 161B | |
-1.74% | 157B |
- Stock Market
- Equities
- ANR Stock
- Company Anatara Lifesciences Ltd